Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.19, in-line with the analyst estimate of $1.19. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.85 billion.

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.